• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

    4.775 -0.145 (-2.95%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 156,825
    Open 4.920
    Bid (Size) 4.770 (600)
    Ask (Size) 4.780 (1,000)
    Prev. Close 4.920
    Today's Range 4.590 - 4.950
    52wk Range 1.590 - 12.46
    Shares Outstanding 6,993,406
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
    Distinguished panel of experts in psychiatry and neuroscience appointed to guide Phase 3 confirmatory trial of roluperidone and broader R&D strategy 
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
    From Minerva Neurosciences, Inc
    Via GlobeNewswire

    Performance

    YTD
    +21.8%
    +21.8%
    1 Month
    +3.1%
    +3.1%
    3 Month
    -8.7%
    -8.7%
    6 Month
    +15.1%
    +15.1%
    1 Year
    +191.2%
    +191.2%

    More News

    Read More
    News headline image
    Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Announces Leadership Transition
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top movers in Wednesday's session ↗
    Via Chartmill
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst ↗
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial ↗
    Via Benzinga
    News headline image
    These stocks are the most active in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    US Stocks Mixed; Coca-Cola Posts Upbeat Earnings ↗
    Via Benzinga
    News headline image
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Minerva Neurosciences, Inc - Common Stock publicly traded?
    Yes, Minerva Neurosciences, Inc - Common Stock is publicly traded.
    What exchange does Minerva Neurosciences, Inc - Common Stock trade on?
    Minerva Neurosciences, Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Minerva Neurosciences, Inc - Common Stock?
    The ticker symbol for Minerva Neurosciences, Inc - Common Stock is NERV on the Nasdaq Stock Market
    What is the current price of Minerva Neurosciences, Inc - Common Stock?
    The current price of Minerva Neurosciences, Inc - Common Stock is 4.775
    When was Minerva Neurosciences, Inc - Common Stock last traded?
    The last trade of Minerva Neurosciences, Inc - Common Stock was at 07/07/26 03:59 PM ET
    What is the market capitalization of Minerva Neurosciences, Inc - Common Stock?
    The market capitalization of Minerva Neurosciences, Inc - Common Stock is 33.39M
    How many shares of Minerva Neurosciences, Inc - Common Stock are outstanding?
    Minerva Neurosciences, Inc - Common Stock has 33M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.